How to buy Seagen stock - 16 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Seagen stock

Own Seagen stock in just a few minutes.

Seagen Inc is a biotechnology business based in the US. Seagen shares (SGEN) are listed on the NASDAQ and all prices are listed in US Dollars. Seagen employs 2,092 staff and has a trailing 12-month revenue of around USD$2.2 billion.

How to buy shares in Seagen

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Seagen. Find the stock by name or ticker symbol: SGEN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Seagen reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Seagen, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Seagen. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Seagen share price

Use our graph to track the performance of SGEN stocks over time.

Seagen shares at a glance

Information last updated 2021-04-09.
52-week rangeUSD$117.91 - USD$213.94
50-day moving average USD$147.9457
200-day moving average USD$173.6586
Wall St. target priceUSD$192.06
PE ratio 42.6439
Dividend yield N/A (0%)
Earnings per share (TTM) USD$3.37

Buy Seagen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Seagen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Seagen under- or over-valued?

Valuing Seagen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Seagen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Seagen's P/E ratio

Seagen's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, Seagen shares trade at around 43x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Seagen's EBITDA

Seagen's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$649.2 million.

The EBITDA is a measure of a Seagen's overall financial performance and is widely used to measure a its profitability.

Seagen financials

Revenue TTM USD$2.2 billion
Operating margin TTM 27.44%
Gross profit TTM USD$1.1 billion
Return on assets TTM 12.02%
Return on equity TTM 22.88%
Profit margin 28.21%
Book value $19.282
Market capitalisation USD$26.1 billion

TTM: trailing 12 months

Shorting Seagen shares

There are currently 2.5 million Seagen shares held short by investors – that's known as Seagen's "short interest". This figure is 18.7% down from 3.1 million last month.

There are a few different ways that this level of interest in shorting Seagen shares can be evaluated.

Seagen's "short interest ratio" (SIR)

Seagen's "short interest ratio" (SIR) is the quantity of Seagen shares currently shorted divided by the average quantity of Seagen shares traded daily (recently around 1.2 million). Seagen's SIR currently stands at 2.13. In other words for every 100,000 Seagen shares traded daily on the market, roughly 2130 shares are currently held short.

However Seagen's short interest can also be evaluated against the total number of Seagen shares, or, against the total number of tradable Seagen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Seagen's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Seagen shares in existence, roughly 10 shares are currently held short) or 0.0407% of the tradable shares (for every 100,000 tradable Seagen shares, roughly 41 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Seagen.

Find out more about how you can short Seagen stock.

Seagen's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Seagen.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Seagen's total ESG risk score

Total ESG risk: 29.88

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Seagen's overall score of 29.88 (as at 12/31/2018) is nothing to write home about – landing it in it in the 56th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Seagen is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Seagen's environmental score

Environmental score: 1.18/100

Seagen's environmental score of 1.18 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Seagen is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Seagen's social score

Social score: 23.34/100

Seagen's social score of 23.34 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Seagen is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Seagen's governance score

Governance score: 10.36/100

Seagen's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Seagen is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Environmental, social, and governance (ESG) summary

Seagen Inc was last rated for ESG on: 2019-01-01.

Total ESG score 29.88
Total ESG percentile 55.9
Environmental score 1.18
Environmental score percentile 5
Social score 23.34
Social score percentile 5
Governance score 10.36
Governance score percentile 5

Seagen share dividends

We're not expecting Seagen to pay a dividend over the next 12 months.

Seagen share price volatility

Over the last 12 months, Seagen's shares have ranged in value from as little as $117.91 up to $213.94. A popular way to gauge a stock's volatility is its "beta".

SGEN.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Seagen's is 0.8792. This would suggest that Seagen's shares are less volatile than average (for this exchange).

Seagen overview

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of metastatic urothelial cancers; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops Tisotumab Vedotin for metastatic cervical cancer and other solid tumors; ladiratuzumab vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; and Merck. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site